ArticleCanada communicable disease report = Releve des maladies transmissibles au Canada2026
Device and surgical procedure-related infections in Canadian acute care hospitals, 2020-2024.
Article in Canada communicable disease report = Releve des maladies transmissibles au Canada, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Healthcare-associated infections (HAIs) are a significant healthcare burden in Canada. National surveillance of HAIs at sentinel acute care hospitals is conducted by the Canadian Nosocomial Infection Surveillance Program. Objective: To describe device and surgical procedure-related HAI epidemiology in Canada from 2020 to 2024. Methods: Data were collected from up to 67 Canadian sentinel acute care hospitals between January 1, 2020 and December 31, 2024 for intensive care unit central line-associated bloodstream infections (ICU-CLABSIs), hip and knee surgical site infections (SSIs), cerebrospinal fluid (CSF) shunt SSIs and paediatric cardiac SSIs. Case counts, rates, patient and hospital characteristics, pathogen distributions and antimicrobial resistance data are presented. Results: Between 2020 and 2024, 1,846 device-related infections and 1,014 surgical procedure-related infections were reported. Rates of ICU-CLABSIs, hip and knee SSIs, CSF shunt SSIs and paediatric cardiac SSIs fluctuated throughout the study period, with no significant trends observed. The most commonly identified pathogens were coagulase-negative staphylococci (37%) in ICU-CLABSIs and Conclusion: Epidemiological and microbiological trends among selected device and surgical procedure-related HAIs are essential for benchmarking infection rates nationally and internationally, identifying any changes in infection rates or antimicrobial resistance patterns and helping inform hospital infection prevention and control and antimicrobial stewardship policies and programs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.